Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2011-03-15
2011-03-15
Mondesi, Robert B (Department: 1645)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007200, C435S007720, C435S007920, C435S007930, C435S007940, C435S069100, C435S069300, C435S252100
Reexamination Certificate
active
07906296
ABSTRACT:
The invention provides compositions and methods for the detection ofAnaplasma platyspolynucleotides and polypeptides.
REFERENCES:
patent: 5192679 (1993-03-01), Dawson et al.
patent: 5401656 (1995-03-01), Dawson et al.
patent: 5413931 (1995-05-01), Dawson et al.
patent: 5726010 (1998-03-01), Clark
patent: 5789176 (1998-08-01), Dawson et al.
patent: 5869335 (1999-02-01), Munderloh et al.
patent: 5928879 (1999-07-01), Dumler et al.
patent: 5955359 (1999-09-01), Dumler et al.
patent: 5976791 (1999-11-01), Mabilat et al.
patent: 5989848 (1999-11-01), Dawson et al.
patent: 6015691 (2000-01-01), Walker et al.
patent: 6025338 (2000-02-01), Barbet et al.
patent: 6034085 (2000-03-01), Joshi et al.
patent: 6204252 (2001-03-01), Murphy et al.
patent: 6207169 (2001-03-01), Reed et al.
patent: 6231869 (2001-05-01), Reed et al.
patent: 6277381 (2001-08-01), Reed et al.
patent: 6284238 (2001-09-01), Coughlin et al.
patent: 6306394 (2001-10-01), Murphy et al.
patent: 6306402 (2001-10-01), Reed et al.
patent: 6355777 (2002-03-01), Walker et al.
patent: 6392023 (2002-05-01), Walker et al.
patent: 6403780 (2002-06-01), Walker et al.
patent: 6458942 (2002-10-01), Walker et al.
patent: 2002/0064531 (2002-05-01), Walker et al.
patent: 2002/0064535 (2002-05-01), Reed et al.
patent: 2002/0068343 (2002-06-01), Reed et al.
patent: 2002/0086984 (2002-07-01), Reed et al.
patent: 2002/0115840 (2002-08-01), Walker et al.
patent: 2002/0132789 (2002-09-01), Barbet et al.
patent: 2003/0194757 (2003-10-01), O'Connor et al.
patent: WO 98/42740 (1998-10-01), None
patent: WO 98/49312 (1998-11-01), None
patent: WO 98/49313 (1998-11-01), None
patent: WO 99/13720 (1999-03-01), None
patent: WO 99/52370 (1999-10-01), None
patent: WO 00/00615 (2000-01-01), None
patent: WO 01/85949 (2001-11-01), None
patent: WO 03/087758 (2003-10-01), None
McBride, et al., “Molecular Cloning of the Gene for a Conserved Major Immunoreactive 28-Kilodalton Protein ofEhrlichia canis: a Potential Serodiagnostic Antigen”, Clinical and Diagnostic Laboratory Immunology, 6:392-399 (1999).
McBride, et al., “A Conserved, Transciptionally Action p28 Multigene Locus ofEhrlichia canis”, Gene 254:245-252 (2000).
Murphy, et al., “Major antigenic proteins of the agent of human granulocytic ehrlichiosis are encoded by members of a multigene family”, Infection and Immunity, 66(8):3711-3781 (1998).
Ohashi, et al., “Cloning and Characterization of Multigenes Encoding the Immunodominant 30-Kilodalton Major Outer Membrane Proteins ofEhrlichia canisand Application of the Recombinant Protein for Serodiagnosis”, Journal of Clinical Microbiology, 36:2671-2680.
Ohashi, et al., “Immunodominant Major Outer Membrane Proteins ofEhrlichia chaffeensisare Encoded by a Polymorphic Multigene Family”, Infection and Immunity, 66:132-139 (1998).
Suksawat, et al., “Seroprevalence ofEhrlichia canis, Ehrlichia equiandEhrlichia Risticiiin sick dogs from North Carolina and Virginia”, Journal Vet. Med. 14:50 (2000).
Yu, et al., “Comparison ofEhrlichia chaffeensisRecombinant Proteins for Serologic Diagnosis of Human Monocytotropic Ehrlichiosis” Journal of Clinical Microbiology, 37:2568-2575 (1999).
Yu, et al., “Genetic Diversity of the 28-Kilodalton Outer Membrane Protein Gene in Human Isolates ofEhrlichia chaffeensis” Journal of Clinical Microbiology, 37-1137-1143 (1993).
Yu, et al., “Characterization of the Complete Transcriptionally ActiveEhrlichia chaffeensis28 kDa Outer Membrane Protein Multigene Family” Gene 248:59-68 (2000).
Asanovich, KM, et al., “Particial Characterization of Cloned Genes Encoding Immunoreactive Proteins ofEhrliciha equiand the agent of Human Granulocytic Ehrlichiosis”, 1996. Ab. Gen. Meet. American Society of Microbiology, Abstract No. D-22, p. 245.
Lodes, MJ, et al., “Serodiagnosis of Human Granulocytic Ehrlichiosis by using Novel Combinations of Immunoreactive Recombinant Proteins”, 2001 Journal of Clinical Microbiology, vol. 39, No. 7, pp. 2471-2473.
Wormser, GP, et al., “False-Positive Lyme Disease Serology in Human Granulocytic Ehrlichiosis”, 1996, Lancet, 347, pp. 981-982.
Magnarelli, LA, “Coexistence of Antibodies to tick-Borne Pathogens of Babesiosis, Ehrlichiosis and Lyme Borrelliosis in Human Sera”, 1995, Journal of Clinical Microbiology, vol. 33, No. 11, pp. 3054-3057.
“Notification List—Notification that new names and new combinations have appeared in vol. 51, part 6 of the IJSEM”, 2002, 52, 5-6, International Journal of Systematic and Evolutionary Microbiology.
International Search Report dated Sep. 17, 1993 for PCT/US03/10131.
GenBank Accession No. ABA26590 dated Mar. 24, 2006.
International Search Report dated Aug. 14, 2008 for PCT/US08/058842.
Uniprot Accession No. A0EWB2 dated Nov. 28, 2006.
Uniprot Accession No. Q3L6L0 dated Nov. 8, 2005.
Uniprot Accession No. Q2QFA4 dated Jan. 26, 2004.
Wange, et al. “Two Monoclonal Antibodies with Defined Epitopes of P44 Major Surface Proteins NeutralizeAnaplasma phagocytophilumby Distinct Mechanisms”, Infection and Immunity, vol. 74, No. 3, p. 1873-1882 (2006).
Anonymous, “Anaplasma phagocytophilumquestions”, Internet article (online), Oct. 17, 2006.
Simpson and Gaunt, “Immunocytochemical detection ofEhrlichia platysantigens in canine blood platelets”, J. Vet. Diagn. Invest. 3:228-231 (1991).
Office action dated Oct. 17, 1997, for corresponding U.S. Appl. No. 11/697,769.
Bowie, et al., “Deciphering the Message in Protein Sequences: Tolerance to Amino Acid Substitutions”, Science, vol. 247, p. 1306-1310 (1990).
Herbert et al., The Dictionary of Immunology, Academic Press, 3rdEdition, London, p. 58-59 (1985).
Roitt, et al., “Immunology”, Mosby, St. Louis, p. 7.7-7.8 (1993).
Holmes, “PSMA specific antibodies and their diagnostic and therapeutic use”, Exp. Opin. Invest. Drugs, 10(3):511-519 (2001).
Colman, “Effects of amino acid sequence changes on antibody-antigen interactions”, Research in Immunology, 145(1):33-36 (1994).
Abaza, et al., “Effects of Amino Acid Substitutions Outside an Antigenic Site on Protein Binding to Monoclonal Antibodies of Predetermined Specificity Obtained by Peptide Immunization: Demonstration with Region 94-100 (Antigenic Site 3)”, Journal of Protein Chemistry, vol. 11, No. 5, p. 433-444 (1992).
Lederman, et al., “A Single Amino Acid Substitution in a Common African Allele of the CD4 Molecule Ablates Binding of the Monoclonal Antibody, OKT4”, Molecular Immunology, vol. 28, No. 11, p. 1171-1181 (1991).
Li, et al., “β-Endorphin omission analogs: Dissociation of immunoreactivity from other biological activities”, Proc. Natl. Acad. Sci. USA, vol. 77, No. 6, p. 3211-3214 (1980).
Beall Melissa Jane
Chandrashekar Ramaswamy
Liu Jiayou
Tyrrell Phyllis Ione
Baskar Padma V
IDEXX Laboratories, Inc.
McDonnell Boehnen & Hulbert & Berghoff LLP
Mondesi Robert B
LandOfFree
Detection of anaplasma platys does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Detection of anaplasma platys, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Detection of anaplasma platys will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2626245